#Congestive Heart Failure

82% Success Rate for HearO® in Early Identification of Congestive Heart Failure (CHF) Through Speech

In a study conducted by Cordio Medical among 180 patients at ten medical centers in Israel, the system identified heart failure an average of 18 days before it occurred. Participants sent one voice sample per day via smartphone, in Hebrew, Russian or Arabic. A total of 460,000 samples were collected.

Restore Medical secured EU funding to promote breakthrough treatment for congestive heart failure patients

Cordio Medical Raises $18 Million in Funding from Ceros and Peregrine Ventures to Accelerate Growth

Investment will support clinical studies, partnerships, operations, and R&D.